Immune failure, infection and survival in chronic lymphocytic leukemia in Denmark.
作者信息
Andersen Michael Asger, Niemann Carsten Utoft
机构信息
Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Denmark.
Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Denmark
出版信息
Haematologica. 2018 Jul;103(7):e330. doi: 10.3324/haematol.2018.197889.
Abstract
摘要
相似文献
1
Immune failure, infection and survival in chronic lymphocytic leukemia in Denmark.丹麦慢性淋巴细胞白血病的免疫功能衰竭、感染与生存情况
Haematologica. 2018 Jul;103(7):e330. doi: 10.3324/haematol.2018.197889.
2
Immune failure, infection and survival in chronic lymphocytic leukemia.慢性淋巴细胞白血病中的免疫功能衰竭、感染与生存
Haematologica. 2018 Jul;103(7):e329. doi: 10.3324/haematol.2018.196543.
3
[Chronic lymphatic leukemia: primary treatment based on biological risk stratification. Danish Society of Hematology].[慢性淋巴细胞白血病：基于生物学风险分层的初始治疗。丹麦血液学会]
Ugeskr Laeger. 2005 Mar 21;167(12-13):1392.
4
Improved survival for patients diagnosed with chronic lymphocytic leukemia in the era of chemo-immunotherapy: a Danish population-based study of 10455 patients.化疗免疫治疗时代慢性淋巴细胞白血病患者生存率的提高：一项基于丹麦10455例患者的人群研究。
Blood Cancer J. 2016 Nov 11;6(11):e499. doi: 10.1038/bcj.2016.105.
5
Danish CLL2-Study revisited: FISH on a cohort with a 20-yr follow-up confirms the validity of the hierarchical model of genomic aberrations in chronic lymphocytic leukaemia.丹麦CLL2研究再探讨：对一个有20年随访的队列进行荧光原位杂交分析，证实了慢性淋巴细胞白血病基因组畸变分层模型的有效性。
Eur J Haematol. 2009 Aug;83(2):156-8. doi: 10.1111/j.1600-0609.2009.01258.x. Epub 2009 Mar 19.
6
Impairments in immune cell function in B cell chronic lymphocytic leukemia.B细胞慢性淋巴细胞白血病中免疫细胞功能的损害。
Semin Oncol. 1998 Feb;25(1):27-33.
7
Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections.慢性淋巴细胞白血病和靶向治疗时代的感染风险：将机制与感染联系起来。
Blood Rev. 2018 Sep;32(5):387-399. doi: 10.1016/j.blre.2018.03.004. Epub 2018 Mar 16.
8
A comparison of chronic leukemic lymphocytic leukemia, chronic subleukemic lymphocytic leukemia, and lymphocytic sarcoma.
Cancer Chemother Rep. 1962 Feb;16:231-4.
9
The top ten clues to understand the origin of chronic lymphocytic leukemia (CLL).理解慢性淋巴细胞白血病（CLL）起源的十大线索。
J Autoimmun. 2015 Jan;56:81-6. doi: 10.1016/j.jaut.2014.10.005. Epub 2014 Nov 10.
10
Chronic lymphocytic leukemia and the central nervous system: a clinical and pathological study.慢性淋巴细胞白血病与中枢神经系统：一项临床与病理研究
Neurology. 1996 Jan;46(1):19-25. doi: 10.1212/wnl.46.1.19.
引用本文的文献
1
Complex Relationships between Diagnostics and Survival in Chronic Lymphocytic Leukemia in Denmark, Finland, Norway, and Sweden.丹麦、芬兰、挪威和瑞典慢性淋巴细胞白血病诊断与生存之间的复杂关系。
Cancers (Basel). 2024 Sep 22;16(18):3229. doi: 10.3390/cancers16183229.
2
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis.预测慢性淋巴细胞白血病中的严重感染：一种简单的风险评分，用于在诊断时对患者进行分层。
Ann Hematol. 2024 May;103(5):1655-1664. doi: 10.1007/s00277-024-05625-y. Epub 2024 Jan 18.
3
Prediction of clinical outcome in CLL based on recurrent gene mutations, CLL-IPI variables, and (para)clinical data.基于复发基因突变、CLL-IPI 变量和（辅助）临床数据预测 CLL 的临床结局。
Blood Adv. 2022 Jun 28;6(12):3716-3728. doi: 10.1182/bloodadvances.2021006351.
4
Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia.免疫参数及免疫功能障碍对慢性淋巴细胞白血病患者预后的影响
Cancers (Basel). 2021 Jul 30;13(15):3856. doi: 10.3390/cancers13153856.
5
Value of influenza vaccines in cancer patients during the coronavirus (COVID-19) pandemic: a cross-sectional study.在冠状病毒（COVID-19）大流行期间癌症患者接种流感疫苗的价值：一项横断面研究。
Support Care Cancer. 2021 Nov;29(11):6225-6231. doi: 10.1007/s00520-021-06204-x. Epub 2021 Apr 10.
6
Machine learning can identify newly diagnosed patients with CLL at high risk of infection.机器学习可以识别新诊断出的 CLL 患者中感染风险较高的患者。
Nat Commun. 2020 Jan 17;11(1):363. doi: 10.1038/s41467-019-14225-8.
7
IgA levels at diagnosis predict for infections, time to treatment, and survival in chronic lymphocytic leukemia.在慢性淋巴细胞白血病中，诊断时的 IgA 水平可预测感染、治疗时间和生存情况。
Blood Adv. 2019 Jul 23;3(14):2188-2198. doi: 10.1182/bloodadvances.2018026591.
本文引用的文献
1
and predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study.慢性淋巴细胞白血病患者治疗前感染的预测因素：一项丹麦全国队列研究。
Haematologica. 2018 Jul;103(7):e300-e303. doi: 10.3324/haematol.2017.182006. Epub 2018 Mar 8.
2
The Danish National Chronic Lymphocytic Leukemia Registry.丹麦国家慢性淋巴细胞白血病登记处。
Clin Epidemiol. 2016 Oct 25;8:561-565. doi: 10.2147/CLEP.S99486. eCollection 2016.
3
Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study.依鲁替尼对体内慢性淋巴细胞白血病肿瘤微环境相互作用的破坏——一项研究者发起的II期研究结果
Clin Cancer Res. 2016 Apr 1;22(7):1572-82. doi: 10.1158/1078-0432.CCR-15-1965. Epub 2015 Dec 9.
4
Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib.接受依鲁替尼治疗的慢性淋巴细胞白血病患者体液免疫部分重建且感染减少。
Blood. 2015 Nov 5;126(19):2213-9. doi: 10.1182/blood-2015-04-639203. Epub 2015 Sep 3.
5
Bruton's tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL).布鲁顿酪氨酸激酶（BTK）的功能对慢性淋巴细胞白血病（CLL）的发展和扩张很重要。
Blood. 2014 Feb 20;123(8):1207-13. doi: 10.1182/blood-2013-07-515361. Epub 2013 Dec 5.
6
Nurture versus nature: the microenvironment in chronic lymphocytic leukemia.培育与天性：慢性淋巴细胞白血病的微环境。
Hematology Am Soc Hematol Educ Program. 2011;2011:96-103. doi: 10.1182/asheducation-2011.1.96.
Zotero 插件